Hemostatic changes in patients with end stage renal disease undergoing hemodialysis

被引:38
作者
Alves Rios, Danyelle Romana [1 ]
Carvalho, Maria das Gracas [1 ]
Lwaleed, Bashir A. [1 ]
Simoes e Silva, Ana Cristina [1 ]
Gomes Borges, Karina Braga [1 ]
SantAna Dusse, Luci Maria [1 ]
机构
[1] Univ Fed Minas Gerais, Fac Farm, Clin & Toxicol Anal Dept, BR-31270901 Belo Horizonte, MG, Brazil
关键词
Hemodialysis; Coagulation; Fibrinolysis; Platelets; End stage renal disease; VASCULAR ACCESS THROMBOSIS; FACTOR PATHWAY INHIBITOR; ENDOTHELIAL-CELL MARKERS; GLYCOPROTEIN-IIB-IIIA; UREMIC PATIENTS; ARTERIOVENOUS-FISTULA; PLATELET-AGGREGATION; TISSUE FACTOR; MAINTENANCE HEMODIALYSIS; GUANIDINOSUCCINIC ACID;
D O I
10.1016/j.cca.2009.11.022
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Patients undergoing hemodialysis may show both thrombotic complications and bleeding abnormalities. Hemostatic changes in patients on hemodialysis may result from alterations in vessel wall integrity and platelet function, and reduced blood flow in the native arteriovenous fistula. Vascular complications represent 20-25% of all hospitalizations of patients on hemodialysis. Literature survey revealed that changes in the hemostatic system may play a major role in vascular complications observed in these patients. Thus, it is essential to investigate hemostatic alterations in patients on hemodialysis so that adequate regimes for anticoagulant therapy could be implemented. In this review we discuss hemostatic abnormalities in end stage renal disease patients undergoing hemodialysis. (c) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:135 / 139
页数:5
相关论文
共 78 条
[21]   CORRELATES OF VASCULAR ACCESS OCCLUSION IN HEMODIALYSIS [J].
GOLDWASSER, P ;
AVRAM, MM ;
COLLIER, JT ;
MICHEL, MA ;
GUSIK, SA ;
MITTMAN, N .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (05) :785-794
[22]  
Gordge M P, 1991, Platelets, V2, P115, DOI 10.3109/09537109109006021
[23]   INCREASED CARDIOVASCULAR RISK-FACTORS AND FEATURES OF ENDOTHELIAL ACTIVATION AND DYSFUNCTION IN DIALYZED UREMIC PATIENTS [J].
GRIS, JC ;
BRANGER, B ;
VECINA, F ;
ALSABADANI, B ;
FOURCADE, J ;
SCHVED, JF .
KIDNEY INTERNATIONAL, 1994, 46 (03) :807-813
[24]   HEMODIALYSIS-ASSOCIATED PLATELET ACTIVATION AND THROMBOCYTOPENIA [J].
HAKIM, RM ;
SCHAFER, AI .
AMERICAN JOURNAL OF MEDICINE, 1985, 78 (04) :575-580
[25]   PLASMA THROMBOMODULIN LEVELS ARE DEPENDENT ON PENAL FUNCTION [J].
HERGESELL, O ;
ANDRASSY, K ;
GEBERTH, S ;
NAWROTH, P ;
GABATH, S .
THROMBOSIS RESEARCH, 1993, 72 (05) :455-458
[26]   INSULIN LEVELS AND FIBRINOLYTIC-ACTIVITY IN PATIENTS WITH END-STAGE RENAL-DISEASE [J].
HONG, SY ;
YANG, DH .
NEPHRON, 1994, 68 (03) :329-333
[27]   FURTHER STUDIES ON PLATELET-INHIBITORY EFFECT OF GUANIDINOSUCCINIC ACID AND ITS ROLE IN UREMIC BLEEDING [J].
HOROWITZ, HI ;
STEIN, IM ;
COHEN, BD ;
WHITE, JG .
AMERICAN JOURNAL OF MEDICINE, 1970, 49 (03) :336-&
[28]   Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis [J].
Inoue, A ;
Wada, H ;
Takagi, M ;
Yamamuro, M ;
Mukai, K ;
Nakasaki, T ;
Shimura, M ;
Hiyoyama, K ;
Deguchi, H ;
Gabazza, EC ;
Mori, Y ;
Nishikawa, M ;
Deguchi, K ;
Shiku, H .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2000, 6 (02) :100-103
[29]  
ISHII H, 1991, THROMB HAEMOSTASIS, V65, P618
[30]   HEMOSTATIC ABNORMALITIES IN RENAL-DISEASE [J].
JUBELIRER, SJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1985, 5 (05) :219-225